Knights of Columbus Asset Advisors LLC

Position in RYTM — Rhythm Pharmaceuticals, Inc.

CIK 1688666 NEW HAVEN, CT

Position in RYTM

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$1,355,775

+$251,765 QoQ

Shares Held

15,589

+51.1% QoQ

Ownership

0.023%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Knights of Columbus Asset Advisors LLC holds $22,508,527 across 17 Biotechnology names. RYTM ranks #6 (6.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	19,677	$3,325,806
2	MIRM	Mirum Pharmaceuticals, Inc.	23,824	$2,200,861
3	MDGL	Madrigal Pharmaceuticals, Inc.	3,707	$1,940,503
4	CGON	CG Oncology, Inc.	23,200	$1,570,176
5	COGT	Cogent Biosciences, Inc.	39,039	$1,502,611
6	RYTM	Rhythm Pharmaceuticals, Inc. This page	15,589	$1,355,775
7	KYMR	Kymera Therapeutics, Inc.	15,872	$1,321,978
8	IDYA	IDEAYA Biosciences, Inc.	39,530	$1,317,139

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,355,775	15,589	+51.1%	Shares	Sole	2026-05-11
2025-12-31	$1,104,010	10,314	—	Shares	Sole	2026-02-09
No filing history on record for this holder in this stock.